Lymphocyte Markers As Predictors Of Responsiveness To Rituximab Among Patients With Idiopathic Nephrotic Syndrome
Clinical trial NCT03501459 · UNKNOWN
Trial details
- NCT number
- NCT03501459
- Sponsor
- National University Health System, Singapore
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2020-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.